We subsequently demonstrated that the NLRP3 inflammasome is activated in coronary microvascular endothelium during NAFLD and the release of cytokines including IL-1β and HMGB1 are elevated in cardiac tissue. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.